Isofols appoints Roy Jonebrant as new acting Chief Financial Officer

Gothenburg, Sweden, March 17, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that Roy Jonebrant has been appointed as the new acting Chief Financial Officer. He succeeds Gustaf Albèrt who is leaving the role as CFO, which was announced at the end of 2022.

Isofols appoints Roy Jonebrant as new acting Chief Financial Officer Read More »